Total Payments
$13,112
2024 Payments
$693.54
Companies
75
Transactions
626
Medicare Patients
5,951
Medicare Billing
$912,283
Payment Breakdown by Category
Food & Beverage$11,090 (84.6%)
Consulting$980.00 (7.5%)
Education$542.29 (4.1%)
Other$500.00 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,090 | 604 | 84.6% |
| Consulting Fee | $980.00 | 5 | 7.5% |
| Education | $542.29 | 14 | 4.1% |
| Honoraria | $500.00 | 3 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,384 | 97 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $794.44 | 40 | $0 (2024) |
| PFIZER INC. | $773.51 | 62 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $755.11 | 46 | $0 (2023) |
| Janssen Biotech, Inc. | $672.50 | 24 | $0 (2024) |
| Merck Sharp & Dohme LLC | $564.60 | 30 | $0 (2024) |
| COMSORT, Inc | $550.00 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $478.72 | 3 | $0 (2024) |
| Lilly USA, LLC | $477.17 | 26 | $0 (2021) |
| Amgen Inc. | $469.82 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $693.54 | 30 | Novartis Pharmaceuticals Corporation ($106.73) |
| 2023 | $940.89 | 35 | Sirtex Medical Inc ($204.15) |
| 2022 | $1,462 | 51 | GlaxoSmithKline, LLC. ($430.00) |
| 2021 | $1,257 | 45 | Athenex Pharmaceutical Division, LLC ($175.00) |
| 2020 | $700.27 | 27 | Athenex Pharmaceutical Division, LLC ($175.00) |
| 2019 | $2,055 | 98 | Janssen Biotech, Inc. ($182.27) |
| 2018 | $2,655 | 153 | Novartis Pharmaceuticals Corporation ($285.55) |
| 2017 | $3,348 | 187 | Novartis Pharmaceuticals Corporation ($429.79) |
All Payment Transactions
626 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Oncology | ||||||
| 12/03/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: DESMOID TUMORS | ||||||
| 10/30/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $32.66 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Oncology | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $34.54 | General |
| 07/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $23.63 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 06/07/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Oncology | ||||||
| 06/06/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $21.84 | General |
| 05/15/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: HEMATOLOGY | ||||||
| 05/13/2024 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: BioOncology | ||||||
| 05/02/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: ONCOLOGY | ||||||
| 04/04/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Oncology | ||||||
| 03/28/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Rare Disease | ||||||
| 03/25/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Oncology | ||||||
| 03/13/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.48 | General |
| 02/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.98 | General |
| 02/01/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $32.84 | General |
| Category: Oncology | ||||||
| 01/25/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,458 | 2,721 | $729,658 | $187,678 |
| 2022 | 12 | 1,535 | 2,978 | $833,479 | $214,533 |
| 2021 | 12 | 1,411 | 3,180 | $957,125 | $258,191 |
| 2020 | 12 | 1,547 | 3,669 | $996,859 | $251,881 |
Total Patients
5,951
Total Services
12,548
Medicare Billing
$912,283
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 228 | 457 | $273,118 | $73,323 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 320 | 564 | $249,288 | $61,034 | 24.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 63 | 63 | $48,132 | $11,908 | 24.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 73 | 75 | $33,525 | $8,920 | 26.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 467 | 1,123 | $35,936 | $8,518 | 23.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 98 | $26,460 | $7,172 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 86 | $26,918 | $6,881 | 25.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 82 | 128 | $22,144 | $6,039 | 27.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $12,411 | $3,287 | 26.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 32 | $288.00 | $252.00 | 87.5% |
| 85046 | Red blood count automated, with additional calculations | Office | 2023 | 28 | 30 | $690.00 | $163.80 | 23.7% |
| 85610 | Blood test, clotting time | Office | 2023 | 14 | 32 | $544.00 | $134.40 | 24.7% |
| 85045 | Red blood count, automated test | Office | 2023 | 11 | 12 | $204.00 | $46.92 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 257 | 559 | $354,406 | $94,543 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 323 | 604 | $269,384 | $66,008 | 24.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 82 | 82 | $64,370 | $17,245 | 26.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 55 | 93 | $32,643 | $8,556 | 26.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 447 | 1,100 | $35,200 | $8,363 | 23.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 55 | 56 | $26,264 | $6,696 | 25.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 99 | $24,255 | $6,450 | 26.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 13 | $8,853 | $2,427 | 27.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 35 | 54 | $7,290 | $1,869 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 24 | $7,680 | $1,442 | 18.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 172 | 233 | $2,097 | $679.35 | 32.4% |
| 85610 | Blood test, clotting time | Office | 2022 | 16 | 61 | $1,037 | $254.44 | 24.5% |
About Dr. John Loscalzo, MD
Dr. John Loscalzo, MD is a Hematology & Oncology healthcare provider based in Bay Shore, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699758482.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Loscalzo, MD has received a total of $13,112 in payments from pharmaceutical and medical device companies, with $693.54 received in 2024. These payments were reported across 626 transactions from 75 companies. The most common payment nature is "Food and Beverage" ($11,090).
As a Medicare-enrolled provider, Loscalzo has provided services to 5,951 Medicare beneficiaries, totaling 12,548 services with total Medicare billing of $912,283. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Bay Shore, NY
- Active Since 11/25/2005
- Last Updated 12/09/2009
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1699758482
Products in Payments
- KEYTRUDA (Biological) $1,050
- OPDIVO (Biological) $652.70
- BLENREP (Biological) $430.00
- KISQALI (Drug) $387.87
- INJECTAFER (Drug) $335.70
- TAGRISSO (Drug) $286.64
- IMBRUVICA (Drug) $281.57
- IMFINZI (Drug) $269.89
- BOSULIF (Drug) $262.12
- SIR-Spheres Microspheres (Device) $204.15
- CYRAMZA (Drug) $198.85
- GILOTRIF (Drug) $190.48
- Ultomiris (Drug) $183.07
- DARZALEX (Biological) $167.54
- Erleada (Drug) $162.24
- PIQRAY (Drug) $158.10
- Abraxane (Drug) $150.19
- VERZENIO (Drug) $149.77
- TASIGNA (Drug) $143.65
- Avastin (Biological) $142.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Bay Shore
Kathy Deng, M.d, M.D
Hematology & Oncology — Payments: $13,054
Hematology & Oncology $13,054
Dr. Mary Puccio, Md, MD
Hematology & Oncology — Payments: $2,959
Hematology & Oncology $2,959
Dr. Jia Llon Yee, M.d, M.D
Hematology & Oncology — Payments: $1,598
Hematology & Oncology $1,598
Gerry Rubin, Md, MD
Hematology & Oncology — Payments: $1,510
Hematology & Oncology $1,510
Ashley D'silva, M.d, M.D
Hematology & Oncology — Payments: $638.87
Hematology & Oncology $638.87
Dr. Kenneth Gold, Md, MD
Hematology & Oncology — Payments: $240.84
Hematology & Oncology $240.84